$HWKN
HAWKINS INC Stock $hwkn

$hwkn Overview Financials Valuation SEC Filings Company Website

2024 Q3 Form 10-Q Financial Statement

#000004625024000021 Filed on July 31, 2024

Income Statement

Concept	2024 Q3	2024 Q2
Revenue	$247.0M	$255.9M
YoY Change	-1.63%	12.16%
Cost Of Revenue	$186.8M	$191.2M
YoY Change	-6.19%	-0.62%
Gross Profit	$60.22M	$64.66M
YoY Change	15.83%	80.98%
Gross Profit Margin	24.38%	25.27%
Selling, General & Admin	$26.48M	$24.86M
YoY Change	35.75%	22.83%
% of Gross Profit	43.97%	38.46%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$9.927M	$9.329M
YoY Change	39.68%	32.01%
% of Gross Profit	16.48%	14.43%
Operating Expenses	$26.48M	$24.86M
YoY Change	35.75%	22.83%
Operating Profit	$33.75M	$39.79M
YoY Change	3.87%	157.0%
Interest Expense	-$1.427M	-$1.263M
YoY Change	24.3%	-8.21%
% of Operating Profit	-4.23%	-3.17%
Other Income/Expense, Net	$673.0K	$159.0K
YoY Change	99.7%	-61.22%
Pretax Income	$32.99M	$38.69M
YoY Change	4.15%	120.85%
Income Tax	$8.873M	$9.808M
% Of Pretax Income	26.9%	25.35%
Net Earnings	$24.12M	$28.88M
YoY Change	2.94%	148.68%
Net Earnings / Revenue	9.76%	11.29%
Basic Earnings Per Share	$1.16	$1.39
Diluted Earnings Per Share	$1.16	$1.38
COMMON SHARES
Basic Shares Outstanding	20.90M shares	20.91M shares
Diluted Shares Outstanding	20.86M shares	20.91M shares

Balance Sheet

Concept	2024 Q3	2024 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments	$7.526M	$8.887M
YoY Change	6.75%	17.46%
Cash & Equivalents	$7.526M	$8.887M
Short-Term Investments
Other Short-Term Assets	$5.563M	$5.503M
YoY Change	34.8%	-14.67%
Inventory	$81.57M	$81.20M
Prepaid Expenses
Receivables	$115.2M	$126.4M
Other Receivables	$0.00	$0.00
Total Short-Term Assets	$209.9M	$222.0M
YoY Change	-7.32%	-4.33%
LONG-TERM ASSETS
Property, Plant & Equipment	$217.5M	$213.6M
YoY Change	14.08%	14.98%
Goodwill	$111.6M	$114.0M
YoY Change	44.19%	47.28%
Intangibles	$123.9M	$124.6M
YoY Change	73.53%	70.49%
Long-Term Investments
YoY Change
Other Assets	$3.163M	$4.980M
YoY Change	-43.92%	6.84%
Total Long-Term Assets	$479.8M	$480.8M
YoY Change	31.28%	34.1%
TOTAL ASSETS
Total Short-Term Assets	$209.9M	$222.0M
Total Long-Term Assets	$479.8M	$480.8M
Total Assets	$689.7M	$702.7M
YoY Change	16.51%	19.0%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$50.96M	$47.80M
YoY Change	-8.35%	-11.0%
Accrued Expenses	$12.70M	$12.50M
YoY Change	18.81%	-27.65%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00
YoY Change
Long-Term Debt Due	$9.913M	$9.913M
YoY Change	0.0%	0.0%
Total Short-Term Liabilities	$92.34M	$97.99M
YoY Change	-2.08%	7.84%
LONG-TERM LIABILITIES
Long-Term Debt	$93.86M	$123.8M
YoY Change	19.79%	21.73%
Other Long-Term Liabilities	$236.0K	$241.0K
YoY Change	-66.09%	-88.92%
Total Long-Term Liabilities	$94.10M	$124.1M
YoY Change	19.04%	19.42%
TOTAL LIABILITIES
Total Short-Term Liabilities	$92.34M	$97.99M
Total Long-Term Liabilities	$94.10M	$124.1M
Total Liabilities	$246.3M	$281.5M
YoY Change	11.48%	17.05%
SHAREHOLDERS EQUITY
Retained Earnings	$410.4M	$390.1M
YoY Change	27.19%	28.98%
Common Stock	$31.27M	$28.14M
YoY Change	-29.92%	-36.98%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$443.4M	$421.2M
YoY Change
Total Liabilities & Shareholders Equity	$689.7M	$702.7M
YoY Change	16.51%	19.0%

Cashflow Statement

Concept	2024 Q3	2024 Q2
OPERATING ACTIVITIES
Net Income	$24.12M	$28.88M
YoY Change	2.94%	148.68%
Depreciation, Depletion And Amortization	$9.927M	$9.329M
YoY Change	39.68%	32.01%
Cash From Operating Activities	$41.63M	$17.59M
YoY Change	19.4%	-46.48%
INVESTING ACTIVITIES
Capital Expenditures	$10.64M	$10.65M
YoY Change	35.11%	-33.5%
Acquisitions		$25.40M
YoY Change
Other Investing Activities	$112.0K	-$245.0K
YoY Change	-354.55%	-103.64%
Cash From Investing Activities	-$10.52M	-$35.80M
YoY Change	34.44%	286.03%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-32.47M	$19.95M
YoY Change	17.83%	-190.02%
NET CHANGE
Cash From Operating Activities	41.63M	$17.59M
Cash From Investing Activities	-10.52M	-$35.80M
Cash From Financing Activities	-32.47M	$19.95M
Net Change In Cash	-1.361M	$1.734M
YoY Change	163.76%	22.11%
FREE CASH FLOW
Cash From Operating Activities	$41.63M	$17.59M
Capital Expenditures	$10.64M	$10.65M
Free Cash Flow	$30.99M	$6.937M
YoY Change	14.82%	-58.82%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2023Q3	us-gaap	Finance Lease Right Of Use Asset Amortization FinanceLeaseRightOfUseAssetAmortization	534000	usd
CY2024Q2	us-gaap	Gain Loss On Investments GainLossOnInvestments	159000	usd
CY2023Q3	us-gaap	Gain Loss On Investments GainLossOnInvestments	337000	usd
CY2024Q2	us-gaap	Share Based Compensation ShareBasedCompensation	1467000	usd
CY2023Q3	us-gaap	Share Based Compensation ShareBasedCompensation	959000	usd
CY2024Q2	us-gaap	Other Operating Activities Cash Flow Statement OtherOperatingActivitiesCashFlowStatement	-65000	usd
CY2024Q2	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	10576000	usd
CY2023Q3	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	9055000	usd
CY2024Q2	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	6037000	usd
CY2023Q3	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-11839000	usd
CY2024Q2	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-7300000	usd
CY2023Q3	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-537000	usd
CY2024Q2	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	-8949000	usd
CY2023Q3	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	-9075000	usd
CY2024Q2	us-gaap	Operating Lease Payments OperatingLeasePayments	834000	usd
CY2023Q3	us-gaap	Operating Lease Payments OperatingLeasePayments	580000	usd
CY2024Q2	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable	9808000	usd
CY2023Q3	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable	8255000	usd
CY2024Q2	us-gaap	Increase Decrease In Other Operating Capital Net IncreaseDecreaseInOtherOperatingCapitalNet	-899000	usd
CY2023Q3	us-gaap	Increase Decrease In Other Operating Capital Net IncreaseDecreaseInOtherOperatingCapitalNet	-2300000	usd
CY2024Q2	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	17586000	usd
CY2023Q3	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	34866000	usd
CY2024Q2	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	10649000	usd
CY2023Q3	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	7873000	usd
CY2023Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	7566000	usd
CY2023Q3	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	199129000	usd
CY2024Q2	us-gaap	Gross Profit GrossProfit	64655000	usd
CY2023Q3	us-gaap	Gross Profit GrossProfit	51991000	usd
CY2024Q2	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	191224000	usd
CY2024Q2	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	24864000	usd
CY2023Q3	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	19504000	usd
CY2024Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	39791000	usd
CY2023Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	32487000	usd
CY2024Q2	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	-1263000	usd
CY2023Q3	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	-1148000	usd
CY2024Q2	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	159000	usd
CY2023Q3	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	337000	usd
CY2024Q2	us-gaap	Income Loss Attributable To Parent IncomeLossAttributableToParent	38687000	usd
CY2023Q3	us-gaap	Income Loss Attributable To Parent IncomeLossAttributableToParent	31676000	usd
CY2024Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	9808000	usd
CY2023Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	8246000	usd
CY2024Q2	us-gaap	Net Income Loss NetIncomeLoss	28879000	usd
CY2023Q3	us-gaap	Net Income Loss NetIncomeLoss	23430000	usd
CY2024Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	20816479	shares
CY2023Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	20907724	shares
CY2024Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	20914085	shares
CY2023Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	21012788	shares
CY2024Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	1.39
CY2023Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	1.12
CY2024Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	1.38
CY2023Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	1.12
CY2024Q2	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0.16
CY2023Q3	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0.15
CY2024Q2	us-gaap	Net Income Loss NetIncomeLoss	28879000	usd
CY2023Q3	us-gaap	Net Income Loss NetIncomeLoss	23430000	usd
CY2024Q2	us-gaap	Unrealized Gain Loss On Derivatives UnrealizedGainLossOnDerivatives	-106000	usd
CY2023Q3	us-gaap	Unrealized Gain Loss On Derivatives UnrealizedGainLossOnDerivatives	749000	usd
CY2024Q2	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	28773000	usd
CY2023Q3	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	24179000	usd
CY2024Q1	us-gaap	Stockholders Equity StockholdersEquity	406026000	usd
CY2024Q2	us-gaap	Common Stock Dividends Per Share Cash Paid CommonStockDividendsPerShareCashPaid	0.16
CY2024Q2	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0.16
CY2024Q2	us-gaap	Dividends Common Stock Cash DividendsCommonStockCash	3358000	usd
CY2024Q2	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	1467000	usd
CY2024Q2	us-gaap	Stock Issued During Period Value Restricted Stock Award Gross StockIssuedDuringPeriodValueRestrictedStockAwardGross	0	usd
CY2024Q2	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	2541000	usd
CY2024Q2	us-gaap	Payments For Repurchase Of Equity PaymentsForRepurchaseOfEquity	9149000	usd
CY2024Q2	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-106000	usd
CY2024Q2	us-gaap	Net Income Loss NetIncomeLoss	28879000	usd
CY2024Q2	us-gaap	Stockholders Equity StockholdersEquity	421218000	usd
CY2023Q2	us-gaap	Stockholders Equity StockholdersEquity	350016000	usd
CY2023Q3	us-gaap	Common Stock Dividends Per Share Cash Paid CommonStockDividendsPerShareCashPaid	0.15
CY2023Q3	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0.15
CY2023Q3	us-gaap	Dividends Common Stock Cash DividendsCommonStockCash	3160000	usd
CY2023Q3	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	959000	usd
CY2023Q3	us-gaap	Stock Issued During Period Value Restricted Stock Award Gross StockIssuedDuringPeriodValueRestrictedStockAwardGross	0	usd
CY2023Q3	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	2140000	usd
CY2023Q3	us-gaap	Stock Issued During Period Value Employee Stock Purchase Plan StockIssuedDuringPeriodValueEmployeeStockPurchasePlan	1147000	usd
CY2023Q3	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	749000	usd
CY2023Q3	us-gaap	Net Income Loss NetIncomeLoss	23430000	usd
CY2023Q3	us-gaap	Stockholders Equity StockholdersEquity	371001000	usd
CY2024Q2	us-gaap	Net Income Loss NetIncomeLoss	28879000	usd
CY2023Q3	us-gaap	Net Income Loss NetIncomeLoss	23430000	usd
CY2024Q2	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	9329000	usd
CY2023Q3	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	7107000	usd
CY2024Q2	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	342000	usd
CY2023Q3	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	0	usd
CY2024Q2	us-gaap	Finance Lease Right Of Use Asset Amortization FinanceLeaseRightOfUseAssetAmortization	782000	usd
CY2023Q3	us-gaap	Other Operating Activities Cash Flow Statement OtherOperatingActivitiesCashFlowStatement	26000	usd
CY2024Q2	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	25400000	usd
CY2023Q3	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	0	usd
CY2024Q2	us-gaap	Payments For Proceeds From Other Investing Activities PaymentsForProceedsFromOtherInvestingActivities	-245000	usd
CY2023Q3	us-gaap	Payments For Proceeds From Other Investing Activities PaymentsForProceedsFromOtherInvestingActivities	-44000	usd
CY2024Q2	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-35804000	usd
CY2023Q3	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-7829000	usd
CY2024Q2	us-gaap	Payments Of Dividends Common Stock PaymentsOfDividendsCommonStock	3358000	usd
CY2023Q3	us-gaap	Payments Of Dividends Common Stock PaymentsOfDividendsCommonStock	3160000	usd
CY2024Q2	us-gaap	Proceeds From Stock Plans ProceedsFromStockPlans	0	usd
CY2023Q3	us-gaap	Proceeds From Stock Plans ProceedsFromStockPlans	1147000	usd
CY2024Q2	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	2541000	usd
CY2023Q3	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	2140000	usd
CY2024Q2	us-gaap	Payments For Repurchase Of Equity PaymentsForRepurchaseOfEquity	9149000	usd
CY2023Q3	us-gaap	Payments For Repurchase Of Equity PaymentsForRepurchaseOfEquity	0	usd
CY2024Q2	us-gaap	Repayments Of Other Debt RepaymentsOfOtherDebt	10000000	usd
CY2023Q3	us-gaap	Repayments Of Other Debt RepaymentsOfOtherDebt	23400000	usd
CY2024Q2	us-gaap	Proceeds From Other Debt ProceedsFromOtherDebt	45000000	usd
CY2023Q3	us-gaap	Proceeds From Other Debt ProceedsFromOtherDebt	0	usd
CY2024Q2	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	19952000	usd
CY2023Q3	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-27553000	usd
CY2024Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	1734000	usd
CY2023Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	-516000	usd
CY2024Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	7153000	usd
CY2024Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	8887000	usd
CY2023Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	7050000	usd
CY2024Q2	us-gaap	Interest Paid Net InterestPaidNet	1347000	usd
CY2023Q3	us-gaap	Interest Paid Net InterestPaidNet	1221000	usd
CY2024Q2	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	1015000	usd
CY2023Q3	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	4771000	usd
CY2024Q2	us-gaap	Revenues Revenues	255879000	usd
CY2023Q3	us-gaap	Revenues Revenues	251120000	usd
CY2024Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	20816479	shares
CY2023Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	20907724	shares
CY2024Q2	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	97606	shares
CY2023Q3	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	105064	shares
CY2024Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	20914085	shares
CY2023Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	21012788	shares
CY2024Q2	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	0	shares
CY2023Q3	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	0	shares
CY2024Q1	us-gaap	Asset Acquisition Contingent Consideration Liability AssetAcquisitionContingentConsiderationLiability	11235000	usd
CY2024Q2	us-gaap	Business Combination Consideration Transferred Liabilities Incurred BusinessCombinationConsiderationTransferredLiabilitiesIncurred	0	usd
CY2024Q2	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	342000	usd
CY2024Q2	us-gaap	Asset Acquisition Contingent Consideration Liability AssetAcquisitionContingentConsiderationLiability	11577000	usd
CY2024Q2	us-gaap	Inventory Finished Goods InventoryFinishedGoods	106079000	usd
CY2024Q1	us-gaap	Inventory Finished Goods InventoryFinishedGoods	99058000	usd
CY2024Q2	us-gaap	Inventory Lifo Reserve InventoryLIFOReserve	24880000	usd
CY2024Q1	us-gaap	Inventory Lifo Reserve InventoryLIFOReserve	24458000	usd
CY2024Q2	us-gaap	Inventory Net InventoryNet	81199000	usd
CY2024Q1	us-gaap	Inventory Net InventoryNet	74600000	usd
CY2024Q2	us-gaap	Lifo Inventory Amount LIFOInventoryAmount	79500000	usd
CY2024Q1	us-gaap	Lifo Inventory Amount LIFOInventoryAmount	76200000	usd
CY2024Q2	us-gaap	Goodwill Goodwill	114000000	usd
CY2024Q1	us-gaap	Goodwill Goodwill	103400000	usd
CY2024Q2	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	182224000	usd
CY2024Q2	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	58888000	usd
CY2024Q2	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	123336000	usd
CY2024Q1	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	171485000	usd
CY2024Q1	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	56086000	usd
CY2024Q1	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	115399000	usd
CY2024Q2	us-gaap	Indefinite Lived Intangible Assets Excluding Goodwill IndefiniteLivedIntangibleAssetsExcludingGoodwill	1227000	usd
CY2024Q2	us-gaap	Indefinite Lived Intangible Assets Excluding Goodwill IndefiniteLivedIntangibleAssetsExcludingGoodwill	1227000	usd
CY2024Q1	us-gaap	Indefinite Lived Intangible Assets Excluding Goodwill IndefiniteLivedIntangibleAssetsExcludingGoodwill	1227000	usd
CY2024Q1	us-gaap	Indefinite Lived Intangible Assets Excluding Goodwill IndefiniteLivedIntangibleAssetsExcludingGoodwill	1227000	usd
CY2024Q2	us-gaap	Intangible Assets Gross Excluding Goodwill IntangibleAssetsGrossExcludingGoodwill	183451000	usd
CY2024Q2	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	58888000	usd
CY2024Q2	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	124563000	usd
CY2024Q1	us-gaap	Intangible Assets Gross Excluding Goodwill IntangibleAssetsGrossExcludingGoodwill	172712000	usd
CY2024Q1	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	56086000	usd
CY2024Q1	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	116626000	usd
CY2024Q2	us-gaap	Long Term Debt LongTermDebt	134000000	usd
CY2024Q1	us-gaap	Long Term Debt LongTermDebt	99000000	usd
CY2024Q2	us-gaap	Unamortized Debt Issuance Expense UnamortizedDebtIssuanceExpense	247000	usd
CY2024Q1	us-gaap	Unamortized Debt Issuance Expense UnamortizedDebtIssuanceExpense	269000	usd
CY2024Q2	hwkn	Totaldebtnetofdebtissuancecosts Totaldebtnetofdebtissuancecosts	133753000	usd
CY2024Q1	hwkn	Totaldebtnetofdebtissuancecosts Totaldebtnetofdebtissuancecosts	98731000	usd
CY2024Q2	us-gaap	Long Term Debt Current LongTermDebtCurrent	9913000	usd
CY2024Q1	us-gaap	Long Term Debt Current LongTermDebtCurrent	9913000	usd
CY2024Q2	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	123840000	usd
CY2024Q1	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	88818000	usd
CY2024Q2	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	-0.25
CY2023Q3	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	-0.26
CY2024Q2	srt	Stock Repurchase Program Number Of Shares Authorized To Be Repurchased StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased	2600000	shares
CY2024Q2	us-gaap	Stock Repurchased During Period Shares StockRepurchasedDuringPeriodShares	105541	shares
CY2024Q2	us-gaap	Stock Repurchased During Period Value StockRepurchasedDuringPeriodValue	9100000	usd
CY2023Q3	us-gaap	Stock Repurchased During Period Value StockRepurchasedDuringPeriodValue	0	usd
CY2024Q2	us-gaap	Stock Repurchase Program Remaining Number Of Shares Authorized To Be Repurchased StockRepurchaseProgramRemainingNumberOfSharesAuthorizedToBeRepurchased	831946	shares
CY2024Q1	us-gaap	Accrued Environmental Loss Contingencies Current AccruedEnvironmentalLossContingenciesCurrent	7700000	usd
CY2024Q2	us-gaap	Accrued Environmental Loss Contingencies Current AccruedEnvironmentalLossContingenciesCurrent	7700000	usd
CY2024Q2	us-gaap	Number Of Reportable Segments NumberOfReportableSegments	3	segment
CY2024Q2	us-gaap	Description Of Basis Of Accounting For Transactions Between Reportable Segments DescriptionOfBasisOfAccountingForTransactionsBetweenReportableSegments	no
CY2024Q2	hwkn	Number Of Operating Segments Aggregated NumberOfOperatingSegmentsAggregated	0	segment
CY2024Q2	us-gaap	Segment Reporting Disclosure Of Major Customers SegmentReportingDisclosureOfMajorCustomers	No
CY2024Q2	us-gaap	Revenues Revenues	255879000	usd
CY2024Q2	us-gaap	Gross Profit GrossProfit	64655000	usd
CY2024Q2	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	24864000	usd
CY2024Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	39791000	usd
CY2023Q3	us-gaap	Revenues Revenues	251120000	usd
CY2023Q3	us-gaap	Gross Profit GrossProfit	51991000	usd
CY2023Q3	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	19504000	usd
CY2023Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	32487000	usd
CY2024Q2	us-gaap	Quarterly Financial Information Segment Reporting Segment Assets Material Change QuarterlyFinancialInformationSegmentReportingSegmentAssetsMaterialChange	No

Files In Submission

Name	View Source	Status
0000046250-24-000021-index-headers.html	Edgar Link	pending
0000046250-24-000021-index.html	Edgar Link	pending
0000046250-24-000021.txt	Edgar Link	pending
0000046250-24-000021-xbrl.zip	Edgar Link	pending
a10qfy2025q1063024ex311.htm	Edgar Link	pending
a10qfy2025q1063024ex312.htm	Edgar Link	pending
a10qfy2025q1063024ex321.htm	Edgar Link	pending
a10qfy2025q1063024ex322.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
hwkn-20240630.htm	Edgar Link	pending
hwkn-20240630.xsd	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
hwkn-20240630_cal.xml	Edgar Link	unprocessable
hwkn-20240630_def.xml	Edgar Link	unprocessable
hwkn-20240630_lab.xml	Edgar Link	unprocessable
hwkn-20240630_pre.xml	Edgar Link	unprocessable
hwkn-20240630_htm.xml	Edgar Link	completed
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$HWKN
HAWKINS INC Stock $hwkn

2024 Q3 Form 10-Q Financial Statement

#000004625024000021 Filed on July 31, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$HWKN HAWKINS INC Stock $hwkn

2024 Q3 Form 10-Q Financial Statement

#000004625024000021 Filed on July 31, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$HWKN
HAWKINS INC Stock $hwkn